Latest Salicylates Stories
OTTAWA, April 10, 2015 /CNW/ - The issue: Ranbaxy Pharmaceuticals Canada Inc., in consultation with Health Canada, is recalling one batch of RAN-Gabapentin, a medication used
- Initial Hepatoren® Phase II study results NASHVILLE, Tenn., March 3, 2015 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.
A daily regimen of low-dose aspirin may not actually help you prevent a heart attack or stroke – in fact, it might actually do more harm than good, according to a new study.
Daily aspirin is recommended for those with existing cardiovascular disease.
New research from Queen Mary University of London (QMUL) reveals taking aspirin can significantly reduce the risk of developing – and dying from – the major cancers of the digestive tract, i.e. bowel, stomach and oesophageal cancer.
A majority of middle-aged men and women eligible to take aspirin to prevent heart attack and stroke do not recall their doctors ever telling them to do so
The risk of developing cancer increases with age.
The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer.
DUBLIN, June 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/twpmjd/global_and)
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.